3rd Annual Clinically Relevant Drug Transporters
|Event Date/Time: Oct 22, 2012||End Date/Time: Oct 24, 2012|
-Network and gain expertise with representatives from the ITC, industry, academia and regulatory bodies
-Gain expert clarification on the FDA and EMA transporter interplay draft guidance with industry experience from Keith Hoffmaster, Novartis and regulatory input from Eva Gil Berglund, Medical Products Agency.
-Hear new innovative case studies from James Clarke (GlaxoSmithKline) and Colin Brown (Newcastle University) for the newest modelling tools and best approaches to model integration
-Increase efficacy and reducing toxicity by improving drug drug interaction knowledge with expert knowledge from industry.
-Implement best practice for in-vitro to in-vivo translation and the move into the clinical field.